Nova Scotia Health Authority Financial Highlights

Return to Home page

Nova Scotia Health Authority Expense Allocation 2016-17

Total Annual Expenditures: $2.060 billion

  • Compensation ($1.465 billion)
  • Utilities and Plant Maintenance ($145 million)
  • Medical and Surgical Supplies ($127 million)
  • Drugs ($102 million)
  • Clinical Research ($56 million)
  • Other ($165 million)

COMPENSATION: Includes all salaries and benefits. Also includes funds allocated for temporary staff.
UTILITIES and PLANT MAINTENANCE: Includes utilities such as fuel, electricity and natural gas, telephone, minor equipment purchases, rentals, various building and equipment maintenance and maintenance supplies.
MEDICAL and SURGICAL SUPPLIES: Includes a variety of medical and surgical supplies such as prosthetics, defibrillators, pacemakers, instruments, needles/gloves/dressings and supplies.
DRUGS: Includes general drugs, anti-infectives and anesthetic gases.
CLINICAL RESEARCH: Includes health innovation, research education and other designated programs.
OTHER: Includes patient care supporting costs such as general office supplies, food, IT, lab supplies, insurance, equipment depreciation, etc.

Other detailed reports can be found in the PDF documents below:
Consolidated Financial Statements

Committee Reports

Committee Report - Finance Audit and Risk
Committee Report - Governance
Committee Report - Health Services Planning
Committee Report - Human Resources
Committee Report - Public Engagement
Committee Report - Quality Improvement and Safety